SequelSEC

OCTAVE SPECIALTY GROUP INC OSG

Surety Insurance · CIK 0000874501 · Fiscal year ends 1231 · Insurer

Revenue
$251.22M
Fiscal year ended 2025-12-31
Net income
-$259.09M
Fiscal year ended 2025-12-31
Total assets
$2.22B
Fiscal year ended 2025-12-31

OCTAVE SPECIALTY GROUP INC (OSG) reported revenue of $251.22M and net income of -$259.09M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from OCTAVE SPECIALTY GROUP INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surety Insurance.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

OCTAVE SPECIALTY GROUP INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$251.22M$235.82M$124.73M$53.61M$282.00M$156.00M$496.00M$511.00M$622.00M$506.77M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net income-$259.09M-$556.09M$4.95M$522.12M-$17.00M-$437.00M-$216.00M$186.00M-$329.00M$74.84M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 47.18Mshares 46.97Mshares 45.64Mshares 45.72Mshares 46.54Mshares 46.15Mshares 45.95Mshares 46.56Mshares 46.56Mshares 45.37M
Pretax income-$101.01M-$59.84M-$24.22M-$35.71M$2.00M-$440.00M-$183.00M$273.00M-$284.00M$105.03M
Income tax expense$5.21M$924.00K$989.00K-$462.00K$18.00M-$3.00M$32.00M$5.00M$44.00M$30.71M
Diluted EPS$-5.93$-11.96$0.18$11.48$-0.61$-9.47$-4.69$3.99$-7.25$1.64
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$191.62M$129.17M$66.98M$56.28M$111.00M$92.00MUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

OCTAVE SPECIALTY GROUP INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalentsUnavailable$29.61M$7.34M$6.33M$17.00M$20.00M$24.00M$63.00M$624.00M$91.02M
Total assets$2.22B$8.06B$8.43B$7.97B$12.30B$13.22B$13.32B$14.59B$23.19BUnavailable
Current assetsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total liabilities$1.14B$6.86B$7.00B$6.65B$11.19B$12.07B$11.78B$12.96B$21.55BUnavailable
Current liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total equity incl. NCI$833.18M$996.12M$1.41B$1.31B$1.10B$1.14B$1.54B$1.63B$1.64B$1.98B
Temporary (mezzanine) equity$252.98M$199.40M$17.08M$19.98M$18.00M$7.00M$0UnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$86.55M$55.38M$9.42MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Goodwill$540.34M$418.23M$69.69M$46.05M$46.00M$46.00MUnavailableUnavailableUnavailableUnavailable
Long-term debt$117.56M$0$508.00M$639.00M$2.23B$2.74B$2.82B$2.93B$991.70MUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

OCTAVE SPECIALTY GROUP INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flowUnavailableUnavailable$200.00M$1.34B-$131.00M-$175.00M-$311.00M-$1.54B-$221.00M$830.31M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailable$435.00M$866.00M$776.00M$432.00M$1.00B$1.59B$1.16B-$453.09M
Financing cash flow$21.36M$28.61M-$717.00K-$2.16B-$657.00M-$303.00M-$691.00M-$585.00M-$412.00M-$318.98M
Net change in cashUnavailableUnavailable$213.00M$38.00M-$12.00M-$46.00M-$2.00M-$541.00M$529.00M$54.33M
Stock-based compensation$9.71M$9.36M$12.27M$11.23M$14.00M$11.00M$12.00M$12.00M$4.00M$5.25M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$29.94M$11.70M$4.51M$14.22MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$41.95M$19.95M$5.23MUnavailable$2.00M$1.00M$0$1.00M$1.00M$1.22M

Derived

OCTAVE SPECIALTY GROUP INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue3.9%4.0%9.8%20.9%5.0%7.1%2.4%2.3%0.6%1.0%
Current ratioUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growth6.5%89.1%132.6%-81.0%80.8%-68.5%-2.9%-17.8%22.7%Unavailable
Net margin-103.1%-235.8%4.0%973.9%-6.0%-280.1%-43.5%36.4%-52.9%14.8%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.14xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable900.0%UnavailableUnavailable1.8%Unavailable29.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OSG in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-04View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

cash flow reconciliationreview2023-12-31

Operating, investing and financing flows differ from the reported change in cash by 421283000, beyond tolerance 4350000.00.